查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970735

電腦刀市場－全球產業規模、佔有率、趨勢、機會、預測：按應用、最終用途、地區和競爭格局分類，2021-2031年

CyberKnife Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球電腦刀市場預計將從 2025 年的 6.3855 億美元成長到 2031 年的 17.2205 億美元，複合年成長率達到 17.98%。

電腦刀系統是一種機器人立體定位放射放射線手術平台，能夠以亞毫米級的精度將高能量輻射精準地輸送到腫瘤部位，為傳統手術提供了一種非侵入性的替代方案。人口老化和全球癌症負擔日益加重是推動這一市場成長的主要因素，這些因素都迫切需要高效、以患者為中心的門診治療方案。根據美國癌症協會2024年的報告顯示，美國新增癌症病例將首次超過200萬例，凸顯了對先進腫瘤治療手段日益成長的迫切需求。

市場概覽
預測期 2027-2031
市場規模：2025年 6.3855億美元
市場規模：2031年 1,722,050,000 美元
複合年成長率：2026-2031年 17.98%
成長最快的細分市場 癌症
最大的市場 北美洲

然而，複雜的報銷機制和嚴格的預先核准要求給醫療機構帶來了沉重的行政負擔，嚴重阻礙了放射外科技術的廣泛應用。這些監管和財務障礙常常導致治療延誤或拒絕，限制了患者獲得這項技術的機會。此外，由於行政流程的複雜性，小規模醫療機構往往難以證明投資收益率，因此在購買專業放射外科設備方面猶豫不決，不敢進行必要的巨額投資。

市場促進因素

全球癌症和腫瘤疾病的日益普及是推動全球電腦刀市場發展的主要因素，也因此迫切需要精準、高通量的治療方法。由於環境因素和人口老化導致發病率上升，醫療系統正優先部署能夠以亞毫米級精度輸送高劑量輻射的先進放射線手術平台。日益加重的疾病負擔進一步凸顯了對非侵入性治療方法的需求，以有效應對複雜病例。世界衛生組織（WHO）於2024年2月發布題為《日益成長的全球癌症負擔》的新聞稿指出，預計到2050年，全球新增癌症病例將超過3500萬例，比2022年成長77%。這一趨勢凸顯了開發可擴展腫瘤解決方案的必要性，這些方案能夠在不影響臨床療效的前提下，處理更多患者。

同時，由於患者對微創放射放射線手術的需求不斷成長，市場也在擴張。與傳統切除術相比，微創放射外科手術可顯著縮短恢復時間和住院時間。患者積極尋求具有更佳組織保護能力的替代療法，醫院也因此被迫投資機器人輔助治療系統，以保持競爭力並滿足患者的這些偏好。這種轉變體現在該領域的大規模資本投資。根據Accuray公司2024年8月發布的財務報告，該公司2024會計年度的總訂單達到3.421億美元，年增10%，這主要得益於系統部署量的增加。此外，該公司2024會計年度的年度淨銷售額達到4.466億美元，顯示該技術正持續廣泛應用。

市場挑戰

嚴格的預核准要求和複雜的報銷機制是全球電腦刀市場擴張的重大障礙。這些行政障礙給醫療機構帶來了沉重的營運負擔，常常迫使他們將臨床資源從治療轉移到處理保險核准。支付模式的不確定性和頻繁的拒賠削弱了進行立體定位放射外科放射線手術所需的財務穩定性。因此，小規模的醫療機構，尤其是資金有限的機構，由於監管環境的不確定性，難以證明投資收益的合理性，因此對投資高成本的機器人平台猶豫不決。

這種就醫延誤的環境直接抑制了治療數量和市場利用率。根據美國放射腫瘤學會 (ASTRO) 2024 年的一項調查，92% 的放射腫瘤科醫生表示，由於預先核准要求，患者治療被延誤；約三分之一的醫生指出，這些行政障礙導致患者放棄治療。當患者因官僚效率低下而無法及時接受治療時，對先進治療方法的需求就會被人為抑制。患者數量的下降不僅會阻礙醫療機構的產生收入，還會為新採用者帶來高風險，最終抑制整個市場的成長。

市場趨勢

全球電腦刀市場正經歷著向低分割和超低分割治療的重大轉變，這種療法減少了治療次數，並將治療集中在高精度療程中。臨床醫師正日益利用此系統亞毫米級的精準度，該系統可在1至5次分割內完成立體定位體外放射治療（SBRT），從而提高患者的治療效率和依從性。這一轉變得到了強力的臨床證據支持，這些證據表明，對於前列腺癌等適應症，更短的治療療程安全有效。根據Accuray公司2024年10月發布的新聞稿，一項發表在《新英格蘭醫學日誌》上的研究顯示，PACE-B試驗表明，接受SBRT治療的患者五年癌症控制率達到95.8%，僅需五天即可達到與傳統長期治療相當的療效。

同時，相關人員正優先考慮建立策略夥伴關係，以拓展新興經濟體市場，尤其是在醫療現代化進程加速的亞太地區。製造商正努力應對複雜的監管環境，並發展本地合資企業，以滿足中國等國家對先進放射治療日益成長的需求。這種以本地市場為導向的策略使他們能夠繞過進口壁壘，並為當地醫院提供具有競爭力的價格。這種地域多元化策略的成功在近期的財務表現中得到了充分體現。根據Investing.com發布的2024年8月財報導，Accuray公司2024會計年度在中國的營收年增27%，這進一步證實了該地區在推動未來市場擴張方面發揮的關鍵作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球電腦刀市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依應用領域（腫瘤、癌症、血管畸形等）
    • 依最終用戶（醫院、門診機構、研究機構、製造商）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美電腦刀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲電腦刀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區電腦刀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲地區電腦刀市場的展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章： 電腦刀在南美洲的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球電腦刀市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Accuray Incorporated
  • Varian Medical Systems Inc.
  • Koninklijke Philips NV
  • Hitachi, Ltd.
  • Mevion Medical Systems
  • Mitsubishi Heavy Industries, Ltd.
  • RaySearch Laboratories
  • Siemens Healthineers AG
  • ViewRay, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23766

The Global CyberKnife Market is projected to expand from USD 638.55 Million in 2025 to USD 1722.05 Million by 2031, achieving a compound annual growth rate of 17.98%. Functioning as a robotic stereotactic radiosurgery platform, the CyberKnife System offers a non-invasive alternative to traditional surgery by delivering high-energy radiation to tumors with sub-millimeter precision. This market growth is primarily fueled by an aging population and the rising global burden of cancer, factors that necessitate efficient, patient-centric outpatient treatment solutions. As reported by the American Cancer Society in 2024, the number of new cancer diagnoses in the United States surpassed 2 million for the first time, highlighting the critical and escalating demand for advanced oncological interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 638.55 Million
Market Size 2031USD 1722.05 Million
CAGR 2026-203117.98%
Fastest Growing SegmentCancer
Largest MarketNorth America

However, widespread adoption is significantly hindered by complicated reimbursement structures and strict prior authorization mandates that impose heavy administrative workloads on healthcare providers. These regulatory and financial hurdles frequently lead to treatment delays or denials, restricting patient access to the technology. Furthermore, these barriers often discourage smaller medical facilities from committing to the substantial capital investment required for such specialized radiosurgery equipment, as the administrative complexities make the return on investment difficult to justify.

Market Driver

The escalating global prevalence of cancer and neoplastic diseases serves as the primary catalyst for the Global CyberKnife Market, creating an urgent need for precise, high-throughput treatment modalities. As incidence rates rise due to environmental factors and aging demographics, healthcare systems are prioritizing advanced radiosurgery platforms capable of delivering potent radiation doses with sub-millimeter accuracy. This increasing disease burden necessitates non-invasive options to manage complex cases efficiently. According to a February 2024 press release from the World Health Organization titled 'Global cancer burden growing,' more than 35 million new cancer cases are predicted for 2050, representing a 77% increase from 2022 levels, a trajectory that underscores the requirement for scalable oncological solutions that can handle higher patient volumes without compromising clinical outcomes.

Simultaneously, the market is expanding due to growing patient demand for minimally invasive radiosurgery, which offers significantly reduced recovery times and shorter hospital stays compared to traditional resection. Patients are actively seeking alternatives with superior tissue-sparing capabilities, compelling hospitals to invest in robotic delivery systems to maintain competitiveness and meet these preferences. This shift is reflected in substantial capital equipment investments within the sector. As noted by Accuray Incorporated in their August 2024 financial results, the company secured gross orders of $342.1 million for the fiscal year, a 10 percent increase driven by system placements. Additionally, the manufacturer's full-year net revenue reached $446.6 million in 2024, illustrating the sustained adoption of this technology.

Market Challenge

Stringent prior authorization requirements and complex reimbursement frameworks constitute a significant barrier to the expansion of the Global CyberKnife Market. These administrative obstacles place a heavy operational burden on healthcare providers, often forcing them to divert clinical resources toward managing insurance approvals rather than delivering care. The unpredictability of payment models and the frequency of claim denials undermine the financial stability required to offer specialized stereotactic radiosurgery. Consequently, medical facilities, particularly smaller centers with limited capital, are discouraged from investing in high-cost robotic platforms, as the return on investment becomes difficult to justify amidst such regulatory uncertainty.

This environment of delayed access directly suppresses procedure volumes and market utilization. According to the American Society for Radiation Oncology in 2024, 92% of radiation oncologists reported that prior authorization requirements caused treatment delays for their patients, with nearly one-third indicating that these administrative barriers led patients to abandon therapy entirely. When bureaucratic inefficiencies prevent patients from accessing timely treatment, the demand for advanced interventions is artificially curtailed. This reduction in patient throughput not only hampers revenue generation for providers but also signals a high-risk landscape for new adopters, effectively stalling broader market growth.

Market Trends

The Global CyberKnife Market is experiencing a decisive shift toward hypofractionated and ultra-hypofractionated regimens, condensing therapy into fewer, high-precision sessions. Clinicians are increasingly utilizing the system's sub-millimeter accuracy to deliver stereotactic body radiation therapy (SBRT) in one to five fractions, thereby improving patient throughput and treatment adherence. This transition is supported by strong clinical evidence validating the safety and efficacy of shortened schedules for indications such as prostate cancer. According to an Accuray Incorporated press release in October 2024 regarding a New England Journal of Medicine study, the PACE-B trial demonstrated that patients treated with SBRT achieved a 95.8 percent five-year cancer control rate, a result comparable to conventional longer regimens but delivered in just five days.

At the same time, stakeholders are prioritizing strategic partnerships to penetrate emerging economies, particularly in the Asia-Pacific region where healthcare modernization is accelerating. Manufacturers are establishing local joint ventures to navigate complex regulatory landscapes and meet the surging demand for advanced radiotherapy in countries like China. These localized strategies allow companies to bypass import barriers and price their systems competitively for regional hospitals. The success of this geographic diversification is evident in recent financial performances; according to an August 2024 Investing.com article on Accuray's earnings, the company reported that China revenue grew 27% year-over-year for fiscal 2024, underscoring the region's critical role in driving future market expansion.

Key Market Players

  • Accuray Incorporated
  • Varian Medical Systems Inc.
  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • Mevion Medical Systems
  • Mitsubishi Heavy Industries, Ltd.
  • RaySearch Laboratories
  • Siemens Healthineers AG
  • ViewRay, Inc.

Report Scope

In this report, the Global CyberKnife Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

CyberKnife Market, By Application

  • Tumor
  • Cancer
  • Vascular malformation
  • Others

CyberKnife Market, By End-use

  • Hospitals
  • Outpatient facilities
  • Research
  • Manufacturing

CyberKnife Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global CyberKnife Market.

Available Customizations:

Global CyberKnife Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global CyberKnife Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Tumor, Cancer, Vascular malformation, Others)
    • 5.2.2. By End-use (Hospitals, Outpatient facilities, Research, Manufacturing)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America CyberKnife Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States CyberKnife Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada CyberKnife Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico CyberKnife Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By End-use

7. Europe CyberKnife Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany CyberKnife Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End-use
    • 7.3.2. France CyberKnife Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom CyberKnife Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy CyberKnife Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain CyberKnife Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By End-use

8. Asia Pacific CyberKnife Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China CyberKnife Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End-use
    • 8.3.2. India CyberKnife Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan CyberKnife Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea CyberKnife Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia CyberKnife Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End-use

9. Middle East & Africa CyberKnife Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia CyberKnife Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE CyberKnife Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa CyberKnife Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End-use

10. South America CyberKnife Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil CyberKnife Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia CyberKnife Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina CyberKnife Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global CyberKnife Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Accuray Incorporated
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Varian Medical Systems Inc.
  • 15.3. Koninklijke Philips N.V.
  • 15.4. Hitachi, Ltd.
  • 15.5. Mevion Medical Systems
  • 15.6. Mitsubishi Heavy Industries, Ltd.
  • 15.7. RaySearch Laboratories
  • 15.8. Siemens Healthineers AG
  • 15.9. ViewRay, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer